Increased serum interleukin-18 concentration is associated with hypoadiponectinemia in obesity, independently of insulin resistance

International Journal of Obesity

Volumn 31, Issue 2, 2007, Pages 221-225

  Straczkowski, M ^a   Kowalska, I ^a   Nikolajuk, A ^a   Otziomek, E ^a   Adamska, A ^a   Karolczuk Zarachowicz, M ^a   Gorska, M ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Adipocytokines; Adiponectin; Insulin resistance; Interleukin 18

Indexed keywords

ADIPONECTIN; INTERLEUKIN 18; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE TOLERANCE; HUMAN; HYPERINSULINEMIA; HYPOADIPONECTINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADIPONECTIN; ADULT; ANTHROPOMETRY; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-18; MALE; OBESITY;

EID: 33846620128     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803421     Document Type: Article

References (22)

1. Festa A, D'Agostino Jr R, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42-47.
2. Fernandez-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003; 24: 278-301.
3. Blankenberg S, Luc G, Ducimetiere P, Arveiler D, Ferrieres J, Amouyel P et al. Interleukin-18 and the risk of coronary heart disease in European men. The Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2003; 108: 2453-2459.
4. Blankenberg S, Tiret L, Bickel C, Peetz D, Cambien F, Meyer J et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002; 106: 24-30.
5. Skurk T, Kolb H, Muller-Scholze S, Rohrig K, Hauner H, Herder C. The proatherogenic cytokine interleukin-18 is secreted by human adipocytes. Eur J Endocrinol 2005; 152: 863-868.
6. Wood IS, Wang B, Jenkins JR, Trayhurn P. The pro-inflammatory cytokine IL-18 is expressed in human adipose tissue and strongly upregulated by TNFalpha in human adipocytes. Biochem Biophys Res Commun 2005; 337: 422-429.
7. Esposito K, Pontillo A, Ciotola M, Di Palo C, Grella E, Nicoletti G et al. Weight loss reduces interleukin-18 levels in obese women. J Clin Endocrinol Metab 2002; 87: 3864-3866.
8. Escobar-Morreale HF, Botella-Carretero JI, Villuendas G, Sancho J, San Milan JL. Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity. J Clin Endocrinol Metab 2004; 89: 806-811.
9. Hung J, McQuillan BM, Chapman CM, Thompson PL, Beilby JP. Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arterioscler Thromb Vasc Biol 2005; 25: 1268-1273.
10. Esposito K, Nappo F, Giugliano F, Di Palo C, Ciotola M, Barbieri M et al. Cytokine milieu tends towards inflammation in type 2 diabetes. Diabetes Care 2003; 26: 1647.
11. Esposito K, Nappo F, Giugliano F, Di Palo C, Ciotola M, Barbieri M et al. Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. Am J Clin Nutr 2003; 78: 1135-1140.
12. Aso Y, Okumura K, Takebayashi K, Wakabayashi S, Inukai T. Relationships of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes. Diabetes Care 2003; 26: 2622-2627.
13. Thorand B, Kolb H, Baumert J, Koenig W, Chambless L, Meisinger C et al. Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002. Diabetes 2005; 54: 2932-2938.
14. Bosch M, Lopez-Bermejo A, Vendrell J, Musri M, Ricart W, Fernandez-Real JM. Circulating IL-18 concentration is associated with insulin sensitivity and glucose tolerance through increased fat-free mass. Diabetologia 2005; 48: 1841-1843.
15. Fischer CP, Perstrup LB, Berntsen A, Eskildesn P, Pedersen BK. Elevated plasma interleukin-18 is amarker of insulin-resistance in type 2 diabetic and non-diabetic humans. Clin Immunol 2005; 117: 152-160.
16. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941-946.
17. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001; 103: 1057-1063.
18. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935.
19. Kowalska I, Straczkowski M, Nikolajuk A, Krukowska A, Kinalska I, Gorska M. Plasma adiponectin concentration and TNF-a system activity in lean non-diabetic offspring of type 2 diabetic subjects. Eur J Endocrinol 2006; 154: 319-324.
20. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-E223.
21. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003; 289: 1799-1804.
22. Lindegaard B, Hansen AB, Gerstoft J, Pedersen BK. High plasma level of interleukin-18 in HIV-infected subjects with lipodystrophy. J Acquir Immune Defic Syndr 2004; 36: 588-593.